R. Hewitt Pate - Jan 20, 2022 Form 4 Insider Report for CHEVRON CORP (CVX)

Signature
/s/ Rose Z. Pierson, Attorney-in-Fact for R. Hewitt Pate
Stock symbol
CVX
Transactions as of
Jan 20, 2022
Transactions value $
-$1,808,694
Form type
4
Date filed
1/24/2022, 03:02 PM
Previous filing
Jan 20, 2022
Next filing
Jan 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVX Common Stock Options Exercise $6.34M +54.5K $116.45 54.5K Jan 20, 2022 Direct F1
transaction CVX Common Stock Options Exercise $1.91M +22.9K +42.06% $83.29 77.4K Jan 20, 2022 Direct F1
transaction CVX Common Stock Sale -$10.1M -77.4K -100% $130.01 0 Jan 20, 2022 Direct F1, F2
holding CVX Common Stock 6.48K Jan 20, 2022 By 401(k) plan
holding CVX Common Stock 12.6K Jan 20, 2022 By Pate Family Trust
holding CVX Common Stock 4.53K Jan 20, 2022 By Spouse Trust F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVX Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -54.5K -100% $0.00* 0 Jan 20, 2022 Common Stock 54.5K $116.45 Direct F4
transaction CVX Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -22.9K -20.06% $0.00 91.3K Jan 20, 2022 Common Stock 22.9K $83.29 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 26, 2021.
F2 This transaction was executed in multiple trades at prices ranging from $130.00 to $130.09. The price reported above reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range provided.
F3 The reporting person disclaims beneficial ownership of the shares held by his spouse's trust, and this report should not be deemed an admission that the reporting person is the beneficial owner of the shares held by his spouse's trust for purposes of Section 16 or for any other purpose.
F4 Option granted 1/30/2013. One-third of the shares subject to the option vested on each of the first, second and third anniversaries of the date of grant.
F5 Option granted 1/27/2016. One-third of the shares subject to the option vested on each of the first, second and third anniversaries of the date of grant.